Clinical/Translational Cancer Immunotherapy

Integrated analysis of a phase 2 study of cemiplimab in advanced cutaneous squamous cell carcinoma: extended follow-up of outcomes and quality of life analysis
Danny Rischin, Nikhil I Khushalani, Chrysalyne D Schmults, Alexander Guminski, Anne Lynn S Chang, Karl D Lewis, Annette M Lim, Leonel Hernandez-Aya, Brett G M Hughes, Dirk Schadendorf, Axel Hauschild, Alesha A Thai, Elizabeth Stankevich, Jocelyn Booth, Suk-Young Yoo, Siyu Li, Zhen Chen, Emmanuel Okoye, Chieh-I Chen, Vera Mastey, Medha Sasane, Israel Lowy, Matthew G Fury, Michael R Migden

Journal for ImmunoTherapy of Cancer Aug 2021, 9 (8) e002757; DOI: 10.1136/jitc-2021-002757
Phase I/II trial of a long peptide vaccine (LPV7) plus toll-like receptor (TLR) agonists with or without incomplete Freund’s adjuvant (IFA) for resected high-risk melanoma
Sapna P Patel, Gina R Petroni, Jason Roszik, Walter C Olson, Nolan A Wages, Kimberly A Chianese-Bullock, Mark Smolkin, Nikole Varhegyi, Elizabeth Gaughan, Kelly T Smith, Kathleen Haden, Emily H Hall, Sacha Gnjatic, Patrick Hwu, Craig L Slingluff

Journal for ImmunoTherapy of Cancer Aug 2021, 9 (8) e003220; DOI: 10.1136/jitc-2021-003220
Hypermethylation of CD19 promoter enables antigen-negative escape to CART-19 in vivo and in vitro
Aneta Ledererova, Lenka Dostalova, Veronika Kozlova, Helena Peschelova, Adriana Ladungova, Martin Culen, Tomas Loja, Jan Verner, Sarka Pospisilova, Michal Smida, Veronika Mancikova

Journal for ImmunoTherapy of Cancer Aug 2021, 9 (8) e002352; DOI: 10.1136/jitc-2021-002352
Phase II study of durvalumab plus tremelimumab as therapy for patients with previously treated anti-PD-1/PD-L1 resistant stage IV squamous cell lung cancer (Lung-MAP substudy S1400F, NCT03373760)
Natasha B Leighl, Mary W Redman, Naiyer Rizvi, Fred R Hirsch, Philip C Mack, Lawrence H Schwartz, James L Wade, William J Irvin, Sreekanth C Reddy, Jeffrey Crawford, Jeffrey D Bradley, Thomas E Stinchcombe, Suresh S Ramalingam, Jieling Miao, Katherine Minichiello, Roy S Herbst, Vassiliki A Papadimitrakopoulou, Karen Kelly, David R Gandara

Journal for ImmunoTherapy of Cancer Aug 2021, 9 (8) e002973; DOI: 10.1136/jitc-2021-002973
Nomogram to predict the outcomes of patients with microsatellite instability-high metastatic colorectal cancer receiving immune checkpoint inhibitors
Filippo Pietrantonio, Sara Lonardi, Francesca Corti, Gabriele Infante, Maria Elena Elez, Marwan Fakih, Priya Jayachandran, Aakash Tushar Shah, Massimiliano Salati, Elisabetta Fenocchio, Lisa Salvatore, Giuseppe Curigliano, Chiara Cremolini, Margherita Ambrosini, Javier Ros, Rossana Intini, Floriana Nappo, Silvia Damian, Federica Morano, Giovanni Fucà, Michael Overman, Rosalba Miceli

Journal for ImmunoTherapy of Cancer Aug 2021, 9 (8) e003370; DOI: 10.1136/jitc-2021-003370
Sensitizing tumors to anti-PD-1 therapy by promoting NK and CD8+ T cells via pharmacological activation of FOXO3
Young Min Chung, Pragya P Khan, Hong Wang, Wen-Bin Tsai, Yanli Qiao, Bo Yu, James W Larrick, Mickey C-T Hu

Journal for ImmunoTherapy of Cancer Dec 2021, 9 (12) e002772; DOI: 10.1136/jitc-2021-002772
Efficacy, safety, and biomarker analysis of Camrelizumab in Previously Treated Recurrent or Metastatic Nasopharyngeal Carcinoma (CAPTAIN study)
Yunpeng Yang, Ting Zhou, Xiaozhong Chen, Jingao Li, Jianji Pan, Xiaohui He, Lizhu Lin, Ying-rui Shi, Weineng Feng, Jianping Xiong, Kunyu Yang, Qitao Yu, Qunling Zhang, Desheng Hu, Yan Sun, Guangyuan Hu, Ping Li, Liangfang Shen, Qin Lin, Ben Zhang, Xiao Qu, Jianjun Zou, Li Zhang, Wenfeng Fang, Yuanyuan Zhao

Journal for ImmunoTherapy of Cancer Dec 2021, 9 (12) e003790; DOI: 10.1136/jitc-2021-003790
Leptomeningeal disease and brain control after postoperative stereotactic radiosurgery with or without immunotherapy for resected brain metastases
Giuseppe Minniti, Gaetano Lanzetta, Luca Capone, Martina Giraffa, Ivana Russo, Francesco Cicone, Alessandro Bozzao, Filippo Alongi, Luca Nicosia, Gioia Fineschi, Luca Marchetti, Tommaso Tufo, Federico Bianciardi, Vincenzo Esposito, PierCarlo Gentile, Sergio Paolini

Journal for ImmunoTherapy of Cancer Dec 2021, 9 (12) e003730; DOI: 10.1136/jitc-2021-003730
Single-cell transcriptomics identifies pathogenic T-helper 17.1 cells and pro-inflammatory monocytes in immune checkpoint inhibitor-related pneumonitis
Amelie Franken, Pierre Van Mol, Sam Vanmassenhove, Elena Donders, Rogier Schepers, Thomas Van Brussel, Christophe Dooms, Jonas Yserbyt, Nico De Crem, Dries Testelmans, Walter De Wever, Kristiaan Nackaerts, Johan Vansteenkiste, Robin Vos, Stéphanie Humblet-Baron, Diether Lambrechts, Els Wauters

Journal for ImmunoTherapy of Cancer Sep 2022, 10 (9) e005323; DOI: 10.1136/jitc-2022-005323
Combination of a novel heat shock protein 90-targeted photodynamic therapy with PD-1/PD-L1 blockade induces potent systemic antitumor efficacy and abscopal effect against breast cancers
Kensuke Kaneko, Chaitanya R Acharya, Hiroshi Nagata, Xiao Yang, Zachary Conrad Hartman, Amy Hobeika, Philip F Hughes, Timothy A J Haystead, Michael A Morse, Herbert Kim Lyerly, Takuya Osada

Journal for ImmunoTherapy of Cancer Sep 2022, 10 (9) e004793; DOI: 10.1136/jitc-2022-004793

Main menu

Clinical/Translational Cancer Immunotherapy

Pages

Log in using your username and password

Main menu

Log in using your username and password

You are here

Clinical/Translational Cancer Immunotherapy

Pages